Joseph Schlessinger
机构: Yale university
每年引用次数
引用次数
引用: 163,975
H-指数: 199
I10-指数 : 542
出版物: 800
Molecular Biology Division, Rh6ne-Poulenc Rorer Central Research, King of Prussia, PA 19406 (USA) and Department of Pharmacology, New York University Medical Center, New York, NY 10016 (USA)
CRAIG A DIONNE , MICHAEL JAYE , JOSEPH SCHLESSINGER
Smpte Journal
1991
Mitogenic Effects of Fibroblast Growth Factors in Cultured Fibroblastsa: Structural Diversity and Binding of FGF Receptors
CRAIG A DIONNE , MICHAEL JAYE , JOSEPH SCHLESSINGER
Annals of the New York Academy of Sciences 638 ( 1) 161 -166
62
1991
AXEL OBERMEIER, RALPH A. BRADSHAW, KLAUS SEEDORF," AXEL CHOIDAS," C JOSEPH SCHLESSINGER, AND AXEL ULLRICH
JOSEPH SCHLESSINGER
Receptor Activation by Antigens, Cytokines, Hormones, and Growth Factors 766 1 -1
1995
CRAIG A. DIONNE, MICHAEL JAYE, AND
JOSEPH SCHLESSINGER
The Fibroblast Growth Factor Family 638 161 -161
1991
The EGF Receptor Protooncogene: Structure, Evolution of Properties of Receptor Mutants
JOSEPH SCHLESSINGER
Academic Press 131 -135
1991
SH2 and SH3 domains
T Pawson , J Schlessingert
Current Biology 3 ( 7) 434 -442
947
1993
Amplification and overexpression of the EGF receptor gene in primary human glioblastomas
T. A. LIBERMANN , H. R. NUSBAUM , N. RAZON , R. KRIS
Journal of Cell Science 1985 161 -172
94
1985
Mutational landscape of uterine and ovarian carcinosarcomas reveals new recurrently-mutated histone core genes as drivers of epithelial-mesenchymal transition
Gulden Menderes , Siming Zhao , Carlton L Schwab , Salvatore Lopez
Cancer Research 76 ( 14_Supplement) 135 -135
2016
UNIDADE, HIBRIDOMA, COMPOSIÇÃO FARMACÊUTICA, MÉTODO PARA IDENTIFICAR UMA UNIDADE, ANTICORPO ISOLADO A UMA UNIDADE DE LIGAÇÃO DE ANTÍGENO DO MESMO, MOLÉCULA PEPTÍDICA, E, USO DA UNIDADE.
Lax Irit , Schlessinger Joseph , Towsky Yarden , Yuzawa Satoru
2014
Compositions and Methods for Treating or Preventing Endocrine FGF23-Linked Diseases
Schlessinger Joseph , Schlessinger Avner , Lee Sangwon , Ung Man-Un
2
2020
Quantitative Methods for Studying the Mobility and Distribution of Receptors on Viable Cells
Elliot L. Elson , Joseph Schlessinger
Springer Netherlands 157 -170
4
1981
Dependence of a Human Squamous Carcinoma and Associated Paraneoplastic Syndromes on the Epidermal Growth Factor Receptor Pathway in Nude Mice
Francoise Bellot , Gregory R. Mundy , Joseph Schlessinger , Toshiyuki Yoneda
Cancer Research 51 ( 9) 2438 -2443
25
1991
Point mutation in the fibroblast growth factor receptor eliminates phosphatidylinositol hydrolysis without affecting neuronal differentiation of PC12 cells
Joseph Schlessinger , Moosa Mohammadi , Patrick Hu , Taly Spivak-Kroizman
Journal of Biological Chemistry 269 ( 20) 14419 -14423
80
1994
EXPRESSION OF FUNCTIONAL EPIDERMAL GROWTH FACTOR RECEPTORS IN A HUMAN HEMATOPOIETIC CELL LINE
Raymond Taetle , Robert Hershberg , Eli Gilboa , John Oval
Cancer Research 51 ( 1) 150 -156
7
1991
Receptor tyrosine phosphatase beta is expressed in the form of proteoglycan and binds to the extracellular matrix protein tenascin.
Gilad Barnea , Martin Grumet , Peter Milev , Joseph Schlessinger
Journal of Biological Chemistry 269 ( 20) 14349 -14352
171
1994
The Binding of Complement by Complexes Formed Between a Rabbit Antibody and Oligosaccharides of Increasing Size
Walter F. Riesen , David Givol , Joseph Schlessinger , Hans Huser
Journal of Immunology 116 ( 5) 1363 -1366
31
1976
Temporal resolution of protein signaling (473.1)
Cristina Furdui , Joseph Schlessinger , BeiBei Luo , Karen Anderson
The FASEB Journal 28
2014
Detailed Genetic and Physical Map of the 3p Chromosome Region Surrounding the Familial Renal Cell Carcinoma Chromosome Translocation, t(3;8)(p14.2;q24.1)
Sal LaForgia , Jerzy Lasota , Farida Latif , Leslie Boghosian-Sell
Cancer Research 53 ( 13) 3118 -3124
36
1993
SU6668 Is a Potent Antiangiogenic and Antitumor Agent That Induces Regression of Established Tumors
Peter Vajkoczy , Laurie M. Strawn , Andreas Thurnher , K. Peter Hirth
Cancer Research 60 ( 15) 4152 -4160
688
2000
COMP 374-Potent inhibitors of mutant-B-Raf and Fms kinases designed using a scaffold-based drug discovery approach
M. Nespi , Nikolas K. Haass , Calvin Settachatgul , Keiran S. M. Smalley
236th National Meeting of the American-Chemical-Society 236
2008
Mark A. Lemmon, Ph.D., F.R.S. Moosa Mohammadi Towia Libermann Elliot Elson Jan Sap Stevan R. Hubbard Lisa Coussens Patrick Hu Lev Lab Julian Downward Richard P. Lifton Greg Plowman Roger Daly Satoru Yuzawa Elior Peles Steven Shoelson V.P. Eswarakumar, Ph.D. Gilad Barnea Daniela Rotin Ricardo Martinez, Ph.D.